找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical Management of Renal Tumors; Ronald M. Bukowski,Andrew C. Novick Book 2008 The Editor(s) (if applicable) and The Author(s), under

[復(fù)制鏈接]
樓主: POL
51#
發(fā)表于 2025-3-30 11:57:41 | 只看該作者
52#
發(fā)表于 2025-3-30 15:03:33 | 只看該作者
53#
發(fā)表于 2025-3-30 16:47:15 | 只看該作者
The Role of Angioinfarction in the Management of Renal Tumors,ogenesis pathways by eliminating the tumor’s blood supply. Angioinfarction of renal tumors may be used to both the surgeon’s and patient’s advantage. Here we review the history, indications, techniques, and complications of angioinfarction in the management of primary renal tumors and their metastas
54#
發(fā)表于 2025-3-30 23:24:51 | 只看該作者
Surveillance Strategies Following Curative Therapy for Localized Renal Cell Carcinoma,lly recurrent and metastatic disease. Assuming that success of clinical intervention at the time of relapse is inversely proportional to the disease burden at the time of salvage treatment, ideal surveillance protocol should allow the earliest identification of potentially treatable recurrences whil
55#
發(fā)表于 2025-3-31 01:18:00 | 只看該作者
Local Recurrence of Renal Cell Carcinoma: ,,l encapsulated. Local recurrence presents unique challenges. This chapter reviews the incidence, risk factors, and management of local recurrence for patients with RCC. Local recurrence occurs primarily as ipsilateral recurrence in the renal fossa after radical nephrectomy and within the residual pa
56#
發(fā)表于 2025-3-31 05:14:06 | 只看該作者
Adjuvant Therapy of Renal Cell Carcinoma,ed studies available do not demonstrate an advantage for pre- or postoperative therapy. Patient selection criteria have varied, but generally high risk groups with T. tumors and lymph node metastases (N.) disease have been included. In the future, adjuvant trials conducted in this group of patients
57#
發(fā)表于 2025-3-31 12:04:58 | 只看該作者
58#
發(fā)表于 2025-3-31 16:56:26 | 只看該作者
Active Surveillance of Localized Renal Tumors,l body imaging. Active surveillance of these lesions has been pursued in elderly or infirm patients. Here we review the current data regarding the growth kinetics, pathology, stage progression, and clinical management of renal masses under active surveillance. The limitations of these data are discussed.
59#
發(fā)表于 2025-3-31 20:04:46 | 只看該作者
The Role of Angioinfarction in the Management of Renal Tumors,ogenesis pathways by eliminating the tumor’s blood supply. Angioinfarction of renal tumors may be used to both the surgeon’s and patient’s advantage. Here we review the history, indications, techniques, and complications of angioinfarction in the management of primary renal tumors and their metastases.
60#
發(fā)表于 2025-3-31 22:13:01 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 13:33
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
方城县| 长宁县| 绥宁县| 上林县| 临朐县| 彭州市| 长寿区| 凌源市| 乌鲁木齐市| 黎川县| 隆林| 营口市| 旬邑县| 桐乡市| 黄龙县| 梅河口市| 永德县| 和顺县| 尼木县| 平泉县| 茶陵县| 都兰县| 洮南市| 扎兰屯市| 宜君县| 泰宁县| 郴州市| 边坝县| 鄂尔多斯市| 且末县| 新绛县| 霍林郭勒市| 玉环县| 临高县| 依兰县| 鄢陵县| 全椒县| 南昌市| 玉溪市| 崇信县| 赤峰市|